traitement diabète

Ozempic: Complete Guide to the Revolutionary Treatment for Type 2 Diabetes

by

Ozempic represents a major advance in the treatment of type 2 diabetes. This injectable medication, based on semaglutide, has revolutionized the management of diabetic patients since its approval by the FDA in 2017 and EMA in 2018, establishing itself as an essential therapeutic reference.

Mounjaro (Tirzepatide): The New Revolutionary Treatment for Diabetes and Weight Loss in 2025

by

Mounjaro, with its active ingredient tirzepatide, marks a significant advancement in treating type 2 diabetes and obesity. This revolutionary drug, developed by Eli Lilly, received FDA approval in May 2022 and EMA approval in September 2022.